Effect of valsartan-eluting stents on the expression of angiotensin II type 2 receptor

Chinese Medical Journal

Volumn 119, Issue 7, 2006, Pages 601-604

  Wang, Lei ^a   Li, Gui Hua ^a   Chen, Hui ^a   Li, Hong Wei ^a   Zhao, Lin ^a   Yao, Dao Kuo ^a   Ding, Rong Jing ^a   Jia, San Qing ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin II; Eluting stent; Neointima; Restenosis; Valsartan

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; VALSARTAN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; DRUG DERIVATIVE; TETRAZOLE DERIVATIVE; VALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG MECHANISM; IN-STENT RESTENOSIS; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROTEIN EXPRESSION; RABBIT; ANGIOCARDIOGRAPHY; ANIMAL; CORONARY BLOOD VESSEL; DRUG DELIVERY SYSTEM; GENETICS; IMMUNOHISTOCHEMISTRY; PATHOLOGY; PHYSIOLOGY; RESTENOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STENT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY VESSELS; DRUG DELIVERY SYSTEMS; IMMUNOHISTOCHEMISTRY; RABBITS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STENTS; TETRAZOLES; VALINE;

EID: 33646842342     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200604010-00015     Document Type: Article

References (7)

1. Peters S, Gotting B, Trummel M, Rust H, Brattstrom A. Valsartan for prevention of restenosis after stenting of type B2/C lesions: the Val-PREST trial. J Invasive Cardiol 2001;13:93-97.
2. Peters S, Trümmel M, Meyners W, Klinikum D. Valsartan versus angiotensin-converting enzyme-inhibition in acute coronary syndrome after successful stent implantation of the culprit lesion-results from the VALVACE trial. Eur Heart J 2003;24 Suppl:S23.
3. Edelman ER, Rogers C. Pathobiologic responses to stenting. Am J Cardiol 1998;81:4E-6E.
4. Loot AE, Roks AJ, Henning RH, Tio RA, Albert JH, Boomsma F, et al. Angiotensin (1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 2002;105:1548-1550.
5. van Belle E, Maurice T, Tio FO, Corseaux D, Dupuis B, McFadden EP, et al. ACE inhibition accelerates endothelial regrowth in vivo: a possible explanation for the benefit observed with ACE inhibitors following arterial injury. Biochem Biophys Res Commun 1997;231: 577-581.
6. Wu L, Iwai M, Nakagami H, Li Z, Chen R, Suzuki J, et al. Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 2001; 104:2716-2721.
7. Suzuki J, Iwai M, Nakagami H, Wu L, Chen R, Sugaya T, et al. Role of angiotensin II-regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation. Circulation 2002;106:847-853.